Table 1 Positive control drug information.

From: Systems pharmacology approaches decipher the anti-cancer efficacy of ethnopharmacological agents in hepatocellular carcinoma

Positive drug

Gradient dose

Starting dose

Product code

Specification (%)

Manufacturer

Doxorubicin hydrochloride

0.1/1/5/10(uM)

20 mM

S17092-25 mg

98

Shanghai yuanye Bio-Technology Co., Ltd

Docetaxel

0.1/1/10/100/1000(uM)

20 mM

D807092-250 mg

98

Guangzhou BaoHui Biomedical Technology Co., Ltd

Gefitinib

0.1/1/5/10(uM)

20 mM

G828597-1 g

98

Shanghai Macklin Biochemical Co., Ltd

HHT (Homoharringtonine)

0.1/1/10/100(nM)

20 mM

H111922-20 mg

 ≥ 98

Shanghai Aladdin Biochemical Technology Co.,Ltd

gemcitabine

1/10/50/100(nM)

20 mM

G824361

99

Shanghai Macklin Biochemical Co., Ltd

Cisplatin

0.01/0.1/1/5/10/20(uM)

20 mM

C14330-500 mg

99

Shanghai JiZhi Biochemical Technology Co., Ltd

Lenvatinib

0.1/1/10/50(uM)

20 mM

E856914-1 g

99

Shanghai Macklin Biochemical Co., Ltd

Benzenepropanoic acid

0.001/0.0002/0.00004/0.000008(uM)

20 mM

P106869-250 mg

99

Shanghai Aladdin Biochemical Technology Co.,Ltd

Sorafenib

0.1/1/5/10(uM)

20 mM

S125098-1 g

 ≥ 99

Shanghai Aladdin Biochemical Technology Co.,Ltd

Cabozantinib

5000/1000/100/10/1/0.1/0.01(nM)

500uM

S41123-10 mg

 ≥ 99

Shanghai yuanye Bio-Technology Co., Ltd